Over 1,000 aspirants, including 62 from India, have been shortlisted for an ambitious private mission to send four men and women on a one-way trip to Mars in 2024 to establish a More »
An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus. The vaccine, described today (March 26, 2015) in the journal Science, was developed by a group led by Yoshihiro Kawaoka, a University of Wisconsin-Madison expert on avian influenza, Ebola and other viruses of medical importance. It differs from other Ebola vaccines because as an inactivated whole virus vaccine, it primes the host immune system with the full complement of Ebola viral proteins and genes, potentially conferring greater protection.
“In terms of efficacy, this affords excellent protection,” explains Kawaoka, a professor of pathobiological sciences in the UW-Madison School of Veterinary Medicine and who also holds a faculty appointment at the University of Tokyo. “It is also a very safe vaccine.”
New research shows bacteria can use tiny magnetic particles to effectively create a ‘natural battery.’ According to work published in journal Science on 27 March, the bacteria can load electrons onto and discharge electrons from microscopic particles of magnetite. This discovery holds out the potential of using this mechanism to help clean up environmental pollution, and other bioengineering applications.
According to study leader Dr James Byrne (Tübingen):”The geochemistry is interesting in itself, but there are also potentially useful implications which may derive form this work. The flow of electrons is critical to the existence of all life and the fact that magnetite can be considered to be redox active opens up the possibility of bacteria being able to exist or survive in environments where other redox active compounds are in short supply in comparison to magnetite.
Antibiotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hospital settings, according to new research at Washington University School of Medicine in St. Louis. The study shows that two genes that confer resistance against a particularly strong class of antibiotics can be shared easily among a family of bacteria responsible for a significant portion of hospital-associated infections.
Drug-resistant germs in the same family of bacteria recently infected several patients at two Los Angeles hospitals. The infections have been linked to medical scopes believed to have been contaminated with bacteria that can resist carbapenems, potent antibiotics that are supposed to be used only in gravely ill patients or those infected by resistant bacteria.